Rapid Acting Antidepressants: Volume 89 by Volume editor Ronald S. Duman (Yale University School of Medicine, CT, USA)
The Advances in Pharmacology series presents a variety of chapters from the best authors in the field.
Rapid Acting Antidepressants
Rapid Acting Antidepressants Summary
About Volume editor Ronald S. Duman (Yale University School of Medicine, CT, USA)
Ronald Duman is at Yale University School of Medicine, CT, USA John Krystal is at Yale University, CT, USA
Table of Contents
Part I Neurobiology of ketamine effects Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission Allie J. Widman and Lori L. McMahon Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition Bernhard Luscher, Mengyang Feng and Sarah J. Jefferson The role of eEF2 kinase in the rapid antidepressant actions of ketamine Kanzo Suzuki and Lisa M. Monteggia Part II The rapid therapeutic effects of ketamine Clinical overview of NMDA-R antagonists and clinical practice Pasha A. Davoudian and Samuel T. Wilkinson Ketamine for depression clinical issues Syed Z. Iqbal and Sanjay J. Mathew Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence Lynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah Neurobiological biomarkers of response to ketamine Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressants Jaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets The emergence of ketamine as a novel treatment for posttraumatic stress disorder Adriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney Part III Novel rapid-acting antidepressant mechanisms related to ketamine mGlu2/3 receptor as a novel target for rapid acting antidepressants Shigeyuki Chaki Involvement of muscarinic receptor mechanisms in antidepressant drug action Jeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions Wayne C. Drevets, Anindya Bhattacharya and Maura L. Furey
Additional information
NPB9780128201893
9780128201893
0128201894
Rapid Acting Antidepressants: Volume 89 by Volume editor Ronald S. Duman (Yale University School of Medicine, CT, USA)
New
Hardback
Elsevier Science Publishing Co Inc
2020-06-26
402
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time